Data / Medical devices / United States / Becton, Dickinson & Co.
Becton, Dickinson & Co.: FDA-registered device maker in San Diego, CA, United States, 22 510(k) clearances
Becton, Dickinson & Co. is registered with the FDA (registration 3007886372) in San Diego, CA, United States. It lists 6 device types. The FDA files 22 510(k) clearances under its listings, the newest dated June 16, 2025. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3007886372
- Address
- 3750 Torrey View Ct, San Diego, CA, United States, 92130
- Owner or operator
- Becton Dickinson and Company (9922032)
- Roles
- Specification developer
- First device listed
- November 18, 2011
- Registered through
- 2027
- Brand names listed
- BD Veritor SARS-CoV-2 & Flu A+B Control Swab Set, BD Veritor SARS-CoV-2 Control Swab Set, BD Veritor System Flu A+B Control Swab Set, BD Veritor System For Rapid Detection of Flu A+B CLIA-waived kit, BD Veritor System For Rapid Detection of Flu A+B Laboratory kit, BD Veritor System For Rapid Detection of RSV - CLIA waived kit, BD Veritor System For Rapid Detection of RSV - Laboratory kit, BD Veritor System Group A Strep Control Swab set and more
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus | GQG | 1 | Specification developer | accessdata.fda.gov |
| Antigens, All Groups, Streptococcus Spp. | GTY | 1 | Specification developer | accessdata.fda.gov |
| Covid-19 Multi-Analyte Antigen Device | QMN | N | Specification developer | accessdata.fda.gov |
| Devices Detecting Influenza A, B, And C Virus Antigens | PSZ | 2 | Specification developer | accessdata.fda.gov |
| Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings | QVF | 2 | Specification developer | accessdata.fda.gov |
| Single (Specified) Analyte Controls (Assayed And Unassayed) | JJX | 1 | Specification developer | accessdata.fda.gov |
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| June 16, 2025 | K243872 | BD Veritor System for SARS-CoV-2 | QVF | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| December 5, 2023 | K232434 | BD Veritor System for Rapid Detection of Flu A+B CLIA Waived Kit | PSZ | Substantially Equivalent | Bd | accessdata.fda.gov |
| January 27, 2023 | K223016 | BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived Kit | PSZ | Substantially Equivalent | Bd | accessdata.fda.gov |
| March 20, 2018 | K180438 | BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit | PSZ | Substantially Equivalent | Bd | accessdata.fda.gov |
| February 25, 2016 | K160164 | BD Veritor System for Rapid Detection of Flu A + B Labratory Kit | PSZ | Substantially Equivalent | Becton, Dickinson & CO | accessdata.fda.gov |
| February 24, 2016 | K160161 | BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit | PSZ | Substantially Equivalent | Becton, Dickinson & CO | accessdata.fda.gov |
| October 27, 2015 | K152874 | BD Veritor System for the Rapid Detection of Flu A + B Laboratory kit | PSZ | Substantially Equivalent | Becton, Dickinson and Co. | accessdata.fda.gov |
| October 27, 2015 | K152870 | BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kit | PSZ | Substantially Equivalent | Becton, Dickinson and Co. | accessdata.fda.gov |
| June 10, 2015 | K151291 | BD Veritor (TM) System for the Rapid Detection of Flu A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| June 8, 2015 | K151301 | BD Veritor System Flu A+B Assay | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| November 15, 2013 | K133140 | BD VERITOR SYSTEM FOR THE RAPID DETECTION OF RSV | GQG | Substantially Equivalent | Becton, Dickinson & CO | accessdata.fda.gov |
| November 13, 2013 | K133138 | BD Veritor System Flu A+B Assay | PSZ | Substantially Equivalent | Becton, Dickinson & CO | accessdata.fda.gov |
| November 7, 2013 | K132456 | BD VERITOR (TM) SYSTEM FOR RAPID DETECTION OF RSV | GQG | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| October 2, 2013 | K132693 | BD Veritor System Flu A+B Assay | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| September 23, 2013 | K132692 | BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| August 7, 2013 | K132259 | BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| August 7, 2013 | K132256 | BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| February 6, 2013 | K122718 | BD VERITOR(TM) SYSTEM FOR RAPID DETECTION OF GROUP A STREP | GTY | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| September 18, 2012 | K121633 | BD VERITOR(TM) SYSTEM FOR THE RAPID DETECTION OF RSV | GQG | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| September 7, 2012 | K121797 | BD VERITOR(TM) SYSTEM FOR RAPID DETECTION OF FLU A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| March 23, 2012 | K120049 | BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
| October 28, 2011 | K112277 | BD VERITOR(TM) SYSTEM FOR RAPID DETECTION OF FLU A+B | PSZ | Substantially Equivalent | Becton, Dickinson and Company | accessdata.fda.gov |
Compare with other makers
- All makers of Devices Detecting Influenza A, B, And C Virus Antigens
- All makers of Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
- All makers of Antigens, All Groups, Streptococcus Spp.
- All makers of Single (Specified) Analyte Controls (Assayed And Unassayed)
- All makers of Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus
- All makers of Covid-19 Multi-Analyte Antigen Device
Updated June 16, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.